Related Experiment Video
Updated: May 24, 2026
08:21
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Inflammatory factors and hypertensive nephropathy: A bidirectional 2-sample Mendelian randomization study.
Yu Yang1, Jianfeng Xue2, Lei Wang3
1Department of Biological Products, Guizhou Center for Disease Control and Prevention, Guiyang, Guizhou Province, China.
Medicine
|May 23, 2026
Summary
This study reveals causal links between specific inflammatory factors and hypertensive nephropathy (HTN). Identifying these connections offers new insights for managing this widespread public health concern.
Area of Science:
- Genetics
- Immunology
- Nephrology
Background:
- Hypertensive nephropathy (HTN) poses a significant global health challenge.
- Understanding the interplay between inflammation and HTN is crucial for effective management.
Purpose of the Study:
- To investigate the causal relationships between 91 inflammatory factors and the risk of hypertensive nephropathy (HTN).
- To explore potential bidirectional causal effects between HTN and inflammatory factor levels.
- To identify underlying biological pathways implicated in HTN development.
Main Methods:
- Utilized a bidirectional 2-sample Mendelian randomization approach.
- Analyzed genome-wide association study data from large population cohorts.
- Performed pathway enrichment analysis to elucidate biological mechanisms.
Main Results:
- Several inflammatory factors showed associations with HTN risk: interleukin-20 receptor subunit alpha, caspase 8, CUB domain-containing protein 1, and stem cell factor were linked to reduced HTN risk.
- Interleukin-18 receptor 1, leukemia inhibitory factor, oncostatin-M, and interferon-gamma were associated with increased HTN risk.
- Identified several biological pathways potentially involved in HTN pathogenesis.
Conclusions:
- Established evidence for causal relationships between multiple inflammatory factors and hypertensive nephropathy.
- Findings provide valuable insights for developing novel disease management strategies and informing public health policies for HTN.
- Highlights the complex interplay between the immune system and hypertension-related kidney disease.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...